IGIQ

Serial Number 98740176
688

Registration Progress

Application Filed
Sep 9, 2024
Under Examination
Jun 17, 2025
Approved for Publication
Apr 22, 2025
Published for Opposition
Apr 22, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 17, 2025 160 days

Trademark Image

IGIQ

Basic Information

Serial Number
98740176
Deadline
December 17, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
September 9, 2024
Published for Opposition
April 22, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jun 17, 2025
Application
Pending
Classes
035 036 044

Rights Holder

CSL Behring L.L.C.

16
Address
1020 First Avenue
King of Prussia, PA 19406

Ownership History

CSL Behring L.L.C.

Original Applicant
16
King of Prussia, PA

CSL Behring L.L.C.

Owner at Publication
16
King of Prussia, PA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
160 days remaining
NOA E-Mailed - SOU Required
Due Date
December 17, 2025
Extension Available
Until June 17, 2026

Application History

8 events
Date Code Type Description
Jun 17, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 22, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 22, 2025 PUBO A PUBLISHED FOR OPPOSITION
Apr 16, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2025 DOCK D ASSIGNED TO EXAMINER
Jan 17, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Providing information regarding medical billing support services, namely, medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance
Class 036
Providing information regarding patient medication reimbursement programs and insurance coverage, namely, reimbursement for immunoglobulin purchases
Class 044
Providing medical information regarding immunoglobulin, immunodeficiency disorders, and treatment of same using immunoglobulin; medical consultation directed toward provision of letters of medical necessity or appeal

Additional Information

Pseudo Mark
IG IQ
Pseudo Mark
IMMUNE GLOBULIN IQ

Classification

International Classes
035 036 044